Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.38 is 52% below its 5-year average of 4.95, near the low end of its 5-year range (2.38–10.13).
As of the fiscal period ended Tuesday, June 30, 2026. 21.22% below its 12-month average of 3.02.
Reported quarterly quick ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 2.38.
QUICK RATIO (ACID-TEST)
2.38
QUICK RATIO (ACID-TEST) AVG TTM
3.02
QUICK RATIO (ACID-TEST) AVG 3Y
4.20
QUICK RATIO (ACID-TEST) AVG 5Y
4.95
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-21.22%
CURRENT VS 3Y AVG
-43.31%
CURRENT VS 5Y AVG
-51.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-28.97%
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.72B
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.02
3Y Avg
4.20
5Y Avg
4.95
Market Cap
$10.69B
Quick Ratio (Acid-Test)
1.04
TTM Avg
1.07
3Y Avg
1.16
5Y Avg
1.16
Market Cap
$10.87B
Quick Ratio (Acid-Test)
1.32
TTM Avg
3.40
3Y Avg
2.88
5Y Avg
2.93
Market Cap
$10.54B
Quick Ratio (Acid-Test)
5.25
TTM Avg
4.17
3Y Avg
4.17
5Y Avg
4.87
Market Cap
$10.97B
Quick Ratio (Acid-Test)
0.73
TTM Avg
1.13
3Y Avg
0.99
5Y Avg
0.98
Market Cap
$10.37B
Quick Ratio (Acid-Test)
2.93
TTM Avg
2.25
3Y Avg
2.88
5Y Avg
3.49
Market Cap
$10.38B
Quick Ratio (Acid-Test)
5.70
TTM Avg
4.14
3Y Avg
3.40
5Y Avg
2.70
Market Cap
$10.14B
Quick Ratio (Acid-Test)
1.28
TTM Avg
1.17
3Y Avg
1.11
5Y Avg
1.16
Market Cap
$10.13B
Quick Ratio (Acid-Test)
1.68
TTM Avg
1.66
3Y Avg
1.58
5Y Avg
1.56
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.72B | 2.38 | 3.02 | 4.20 | 4.95 |
| Universal Health Services, Inc. (UHS)vs › | $10.69B | 1.04 | 1.07 | 1.16 | 1.16 |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 1.32 | 3.40 | 2.88 | 2.93 |
| 10x Genomics, Inc. (TXG)vs › | $10.54B | 5.25 | 4.17 | 4.17 | 4.87 |
| The Cooper Companies, Inc. (COO)vs › | $10.97B | 0.73 | 1.13 | 0.99 | 0.98 |
| Globus Medical, Inc. (GMED)vs › | $10.37B | 2.93 | 2.25 | 2.88 | 3.49 |
| ImmunityBio, Inc. (IBRX)vs › | $10.38B | 5.70 | 4.14 | 3.40 | 2.70 |
| Align Technology, Inc. (ALGN)vs › | $10.14B | 1.28 | 1.17 | 1.11 | 1.16 |
| Molina Healthcare, Inc. (MOH)vs › | $10.13B | 1.68 | 1.66 | 1.58 | 1.56 |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 3.35 | 2.87 | 2.99 | 2.87 |
Quick Ratio
2.38
Excludes inventory
Current Ratio
2.67
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.38 |
| 2026-03-31 | 2.42 |
| 2025-12-31 | 3.37 |
| 2025-09-30 | 3.33 |
| 2025-06-30 | 3.60 |
| 2025-03-31 | 4.24 |
| 2024-12-31 | 4.62 |
| 2024-09-30 | 4.54 |
| 2024-06-30 | 4.52 |
| 2024-03-31 | 5.06 |
| 2023-12-31 | 5.51 |
| 2023-09-30 | 5.35 |
| 2023-06-30 | 5.62 |
| 2023-03-31 | 6.23 |
| 2022-12-31 | 5.93 |
| 2022-09-30 | 6.15 |
| 2022-06-30 | 6.27 |
| 2022-03-31 | 7.32 |
| 2021-12-31 | 4.31 |
| 2021-09-30 | 8.16 |
| 2021-06-30 | 10.13 |
| 2021-03-31 | 14.64 |
| 2020-12-31 | 16.74 |
| 2020-09-30 | 8.95 |
| 2020-06-30 | 10.56 |
| 2020-03-31 | 8.26 |
| 2019-12-31 | 2.11 |
| 2019-09-30 | 5.03 |
| 2019-06-30 | 6.96 |
| 2019-03-31 | 6.27 |
| 2018-12-31 | 7.43 |
| 2018-09-30 | 4.84 |
| 2018-06-30 | 5.50 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 6.97 |
| 2017-06-30 | 0.00 |
